![]() |
市場調査レポート
商品コード
1802010
医薬品用ゼラチンの世界市場規模、シェア、成長分析:製品タイプ別、用途別、供給源別、エンドユーザー別、地域別 - 産業予測(2025年~2032年)Pharmaceutical Gelatin Market Size, Share, and Growth Analysis, By Product Type (Type A, Type B), By Application (Capsules, Tablets), By Source, By End-User, By Region - Industry Forecast 2025-2032 |
||||||
|
医薬品用ゼラチンの世界市場規模、シェア、成長分析:製品タイプ別、用途別、供給源別、エンドユーザー別、地域別 - 産業予測(2025年~2032年) |
出版日: 2025年08月26日
発行: SkyQuest
ページ情報: 英文 176 Pages
納期: 3~5営業日
|
世界の医薬品用ゼラチンの市場規模は、2023年に11億米ドルと評価され、2024年の11億6,000万米ドルから2032年には17億5,000万米ドルに成長し、予測期間(2025年~2032年)のCAGRは5.3%で成長する見通しです。
世界の医薬品用ゼラチン市場は、高齢者人口の増加と慢性疾患の有病率の上昇に後押しされた、カプセルおよびゼラチンベースの医薬品需要の増加によって成長が見込まれています。バイオ医薬品とワクチン開発の急増が市場の可能性をさらに高めています。ソフトジェルやハードカプセル製剤の人気は、消費者が投薬に摂取しやすい選択肢を求めていることから、ゼラチンの不可欠な役割を裏付けています。さらに、特に健康志向の市場で拡大する栄養補助食品部門も、この動向にプラスに寄与しています。しかし、市場は動物由来のゼラチンに関する懸念や、食事や宗教上の制限といった課題に直面しており、植物由来の代替品へのシフトを促しています。こうした要因は、特定の地域ではより広範な戦略の妨げとなる可能性がありますが、業界内では技術革新の機会となります。
Global Pharmaceutical Gelatin Market size was valued at USD 1.1 billion in 2023 and is poised to grow from USD 1.16 billion in 2024 to USD 1.75 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).
The global pharmaceutical gelatin market is poised for growth driven by an increasing demand for capsule and gelatin-based medications, fueled by a growing geriatric population and the rising prevalence of chronic diseases. The surge in biopharmaceuticals and vaccine development further enhances market potential. The popularity of soft gel and hard capsule formulations underscores the integral role of gelatin, as consumers seek easy-to-consume options for medication. Additionally, the expanding nutraceutical sector, particularly in health-conscious markets, contributes positively to this trend. However, the market faces challenges from concerns regarding animal-derived gelatin, along with dietary and religious restrictions, prompting a shift toward plant-based alternatives. Although these factors may hinder broader strategies in certain regions, they provide opportunities for innovation within the industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Gelatin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Gelatin Market Segments Analysis
Global Pharmaceutical Gelatin Market is segmented by Product Type, Application, Source, End-User and region. Based on Product Type, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Capsules, Tablets, Suppositories and Vaccines. Based on Source, the market is segmented into Porcine, Bovine and Fish. Based on End-User, the market is segmented into Pharmaceuticals, Nutraceuticals and Cosmetics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Gelatin Market
The increasing demand for pharmaceutical products in capsule form is significantly fueling the Global Pharmaceutical Gelatin market. Gelatin capsules offer advantages such as ease of swallowing and enhanced bioavailability, making them a vital component in both prescription and over-the-counter medications. This growing interest among consumers and healthcare providers underscores the importance of gelatin in the pharmaceutical industry, leading to consistent and robust market growth. The versatility and functional benefits of gelatin capsules continue to contribute to their popularity, further solidifying their role in the development of innovative drug delivery systems across various therapeutic areas.
Restraints in the Global Pharmaceutical Gelatin Market
The rising inclination towards vegan, vegetarian, and plant-based lifestyles has significantly shifted consumer preferences towards non-animal gelatin alternatives. This trend is particularly evident in the nutraceutical and dietary supplement sectors, where the demand for plant-based capsules is gaining traction. Consequently, traditional gelatin products face growing competition, especially in markets where health-consciousness and vegan considerations are paramount. This shift poses a challenge for manufacturers of animal-derived gelatin, as they must adapt to the changing landscape and address the needs of consumers who prioritize ethical and health-related factors in their purchasing decisions.
Market Trends of the Global Pharmaceutical Gelatin Market
The global pharmaceutical gelatin market is witnessing significant growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular issues, and arthritis, which necessitate consistent medication solutions. The demand for patient-friendly drug delivery formats, particularly gelatin capsules and soft gel capsules, is rising due to their ease of administration and precise dosing. This preference for convenient and effective medication delivery is propelling the expansion of the pharmaceutical gelatin market across various therapeutic segments. As healthcare providers seek innovative ways to enhance patient compliance and treatment outcomes, the versatility and functionality of gelatin in pharmaceuticals continue to bolster market potential.